T
Todd H. Baron
Researcher at University of North Carolina at Chapel Hill
Publications - 818
Citations - 40963
Todd H. Baron is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Stent & Endoscopic retrograde cholangiopancreatography. The author has an hindex of 98, co-authored 795 publications receiving 36063 citations. Previous affiliations of Todd H. Baron include University of Rochester & Miles College.
Papers
More filters
Journal ArticleDOI
Endoscopic band ligation of rectal varices: a case series.
Journal ArticleDOI
Endoscopic treatment of nonstricture-related benign biliary diseases using covered self-expandable metal stents.
Shayan Irani,Todd H. Baron,Ryan Law,Ali Akbar,Andrew S. Ross,Michael Gluck,Ian Gan,Richard A. Kozarek +7 more
TL;DR: Nonstricture BBD can be effectively and safely treated with the short term placement of CSEMS, and the main outcome measures were resolution of perforation, bleeding, leak, and adverse events related to CSEMS treatment.
Journal ArticleDOI
Successful endoscopic management of biliary cast syndrome in nonliver transplant patients.
TL;DR: 2 patients with biliary cast syndrome in a nonliver transplant setting were described and the casts were managed endoscopically.
Journal ArticleDOI
Use of covered self-expandable metal stents for endoscopic management of benign biliary disease not related to stricture (with video).
Ali Akbar,Shayan Irani,Todd H. Baron,Mark Topazian,Bret T. Petersen,Christopher J. Gostout,Michael J. Levy,Ian Gan,Michael Gluck,Andrew S. Ross,Richard A. Kozarek +10 more
TL;DR: The performance status scale for Head and Neck Cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale and a study of utility and validity.
Journal ArticleDOI
Esophageal self-expandable stent material and mesh grid density are the major determining factors of external beam radiation dose perturbation: results from a phantom model.
TL;DR: Stent characteristics should be considered when selecting the optimal stent for treatment and palliation of malignant esophageal strictures, especially when adjuvant or neo-adjuvant radiotherapy is planned.